on DIAGNOSTIC MEDICAL (EPA:ALDMS)
Diagnostic Medical's Mid-Year Liquidity Report FY2026
Diagnostic Medical Systems disclosed its half-year results for the liquidity contract maintained by DMS Group, as of June 30, 2026. The liquidity account, managed by Natixis Oddo BHF, held 162,636 shares and €38,363 at the end of the reporting period. This marks a change from May 7, 2025, when the account contained 150,000 shares and €50,000.
Between January 1 and June 30, 2026, the company executed 751 purchase transactions and 807 sales. In terms of volume, 209,911 shares were acquired for €274,416, while 157,905 shares were sold for €210,429.
Upcoming financial announcements include the Q2 2026 revenue on July 20 and H1 2026 results on September 15. These will follow the closure of the Euronext Paris market.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DIAGNOSTIC MEDICAL news